Benefit With No Target: Long-Term Outcomes of Chemoimmunotherapy in "PD-L1 Negative" NSCLC. Perrone F, Leonetti A, Tiseo M, Facchinetti F, et al. J Thorac Oncol 2024;19:1128-1132.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Perrone F, Leonetti A, Tiseo M, Facchinetti F, et al. Benefit With No Target: Long-Term Outcomes of Chemoimmunotherapy in "PD-L1 Negative" NSCLC. J Thorac Oncol 2024;19:1128-1132.
PMID: 39111997